Presepsin as a Diagnostic and Prognostic Biomarker in Suspected Sepsis: Correlation with qSOFA and NEWS Scores and Implications for Antimicrobial Stewardship
Journal of Pharmacy and Bioallied Sciences · 2026-10 · 18 (4) · 314-316
DOI: 10.4103/jpbs.jpbs_223_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Bioallied Sciences, online erschienen am 17.11.2026. Verfasst von Seetha Rami Reddy Mallampati und 4 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Sepsis
Abstract (Originalsprache)
A BSTRACT Background: Sepsis remains a major cause of morbidity and mortality worldwide. Early diagnosis and prompt initiation of appropriate antimicrobial therapy are essential for improving outcomes. Presepsin (soluble CD14 subtype) has emerged as a novel biomarker reflecting innate immune activation during bacterial infection. This study evaluated the diagnostic and prognostic significance of presepsin in adult patients with suspected sepsis and explored its relationship with qSOFA and National Early Warning Score (NEWS) severity scores.
Aim
To assess the diagnostic and prognostic utility of serum presepsin in suspected sepsis and determine its correlation with qSOFA and NEWS severity scores. Methodology: A hospital-based cross-sectional observational study was conducted among 80 adult patients admitted with suspected sepsis. Clinical severity was assessed using qSOFA and NEWS scores. Serum presepsin levels were measured by ELISA. Data were analyzed using SPSS software. Nonparametric tests and Fisher exact test were used, with P < 0.05 considered significant.
Results
The mean age was 56.7 ± 13.8 years, and 70% were men. Elevated presepsin (>382 pg/mL) was observed in 95% of patients. High-risk qSOFA and NEWS scores were present in 37.5% and 33.8% of patients, respectively. The mean presepsin level was 614.7 ± 123.3 pg/mL. No significant association was found between presepsin levels and qSOFA categories ( P = 0.147), NEWS categories ( P = 0.168), or in-hospital mortality ( P = 1.000). Mortality rate was 8.8%.
Conclusion
Presepsin demonstrated high diagnostic sensitivity for suspected sepsis but showed limited prognostic value in predicting severity and mortality. Integration of presepsin into antimicrobial stewardship programs may facilitate early therapeutic decision making.
Zitieren
APA
Mallampati, S. R. R., Mhatre, R. R., Rajendran, B., Frank, P., & Periasamy, P. (2026). Presepsin as a Diagnostic and Prognostic Biomarker in Suspected Sepsis: Correlation with qSOFA and NEWS Scores and Implications for Antimicrobial Stewardship. Journal of Pharmacy and Bioallied Sciences, 18(4), 314-316. https://doi.org/10.4103/jpbs.jpbs_223_26
Vancouver
Mallampati SRR, Mhatre RR, Rajendran B, Frank P, Periasamy P. Presepsin as a Diagnostic and Prognostic Biomarker in Suspected Sepsis: Correlation with qSOFA and NEWS Scores and Implications for Antimicrobial Stewardship. Journal of Pharmacy and Bioallied Sciences. 2026;18(4):314-316. doi:10.4103/jpbs.jpbs_223_26
BibTeX
@article{Mallampati2026,
author = {Mallampati, Seetha Rami Reddy and Mhatre, Riddhi R. and Rajendran, Babu and Frank, P. and Periasamy, Panneerselvam},
title = {Presepsin as a Diagnostic and Prognostic Biomarker in Suspected Sepsis: Correlation with qSOFA and NEWS Scores and Implications for Antimicrobial Stewardship},
journal = {Journal of Pharmacy and Bioallied Sciences},
year = {2026},
volume = {18},
number = {4},
pages = {314--316},
doi = {10.4103/jpbs.jpbs_223_26}
}
EUVIMED